Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)
WuXi Advanced Therapies
Programmatic AI Search & Model Visibility Audit
Share of Model (SOM)The percentage of time frontier AI models (ChatGPT, Claude, Gemini) recommend this brand for high-intent category queries.
0.0%
0.0% 30-Day MomentumThe rolling 30-day change in algorithmic Share of Model. Positive momentum indicates increasing AI mindshare.
🧠 Neural Valency:VulnerableThe contextual sentiment of the AI's recommendation. 'Dominant' implies strong conviction, while 'Vulnerable' implies the model heavily conditions its recommendation.
Algorithmic Threat Detection
Primary Competitor Threat
Lonza
Competitor Displacement Rate
5.0%
Competitors are displacing WuXi Advanced Therapies in 5.0% of high-intent buyer queries.The frequency at which AI models actively suggest a competitor as a superior alternative to this brand.
Algorithmic Rationale: WuXi Advanced Therapies appears to have limited direct online visibility for core CDMO services. Competitors like Lonza are more prominently featured for cell and gene therapy manufacturing solutions.
Missing AI Citations:High-authority domains (e.g., Reddit, G2) that models cite to justify recommending competitors, where this brand currently lacks presence.
[linkedin.com][fiercebiotech.com]⚠️ Identified Vulnerability:Market Presence
Primary Threat Identified:Lonza
Target Persona:Biotech R&D Directors
🚨 Threat Velocity:4/10An algorithmic urgency score (1-10) indicating how rapidly competitors are capturing this brand's historical AI search share.
Unlock Full Threat Report (30 Free Credits)